{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:10:11Z","timestamp":1792444211043,"version":"4.5.0"},"reference-count":100,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Bronchiectasis is a heterogeneous chronic airway disease traditionally viewed as neutrophil-driven. Emerging evidence demonstrates distinct complex inflammatory phenotypes influencing clinical outcomes, prognosis and therapeutic options. A narrative review was conducted, informed by a structured literature search on PubMed and Google Scholar databases, focusing on inflammatory phenotypes in bronchiectasis. Based on the prevalent cellular population, four distinct phenotypes can be described. The most common is the neutrophilic phenotype, which is associated with frequent Pseudomonas infection, severe disease, exacerbations and poor prognosis. Targeted novel-agents for this group such as brensocatib (neutrophil protease inhibition) emerge. The eosinophilic phenotype is defined by elevated blood or sputum eosinophils and is associated with FeNO, IL-5\/IL-13 signaling, a possible response to inhaled corticosteroids and biologic agents. The mixed phenotype demonstrates dual neutrophilic and Th2 inflammation. Paucigranulocytic phenotypes remain poorly characterized but with distinct characteristics. Finally, dysregulation of macrophages and lymphocytes as inflammation mediators needs to be studied further. Recent advances have introduced a variety of therapeutic strategies targeting specific inflammatory pathways. Bronchiectasis has a spectrum of inflammatory phenotypes with distinct biological and clinical implications. Recognition and better understanding of inflammatory phenotypes in bronchiectasis may enable opportunities for personalized precision medicine through the transition from empirical management to biomarker-guided, personalized care.<\/jats:p>","DOI":"10.3390\/jpm15100499","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T07:33:50Z","timestamp":1760686430000},"page":"499","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Inflammatory Phenotypes of Bronchiectasis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9770-173X","authenticated-orcid":false,"given":"Evangelia","family":"Koukaki","sequence":"first","affiliation":[{"name":"1st Respiratory Medicine Department of National and Kapodistrian University of Athens, Sotiria Chest Diseases Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Papaiakovou","sequence":"additional","affiliation":[{"name":"1st Respiratory Medicine Department of National and Kapodistrian University of Athens, Sotiria Chest Diseases Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3142-2948","authenticated-orcid":false,"given":"Argyri","family":"Klironomou","sequence":"additional","affiliation":[{"name":"1st Respiratory Medicine Department of National and Kapodistrian University of Athens, Sotiria Chest Diseases Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthymia","family":"Theofani","sequence":"additional","affiliation":[{"name":"Cellular Immunology Laboratory, Center for Basic Research, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1941-0213","authenticated-orcid":false,"given":"Andreas M.","family":"Matthaiou","sequence":"additional","affiliation":[{"name":"5th Respiratory Medicine Department, Sotiria Chest Diseases Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adamantia","family":"Liapikou","sequence":"additional","affiliation":[{"name":"5th Respiratory Medicine Department, Sotiria Chest Diseases Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4925-2332","authenticated-orcid":false,"given":"Nektarios","family":"Anagnostopoulos","sequence":"additional","affiliation":[{"name":"1st Respiratory Medicine Department of National and Kapodistrian University of Athens, Sotiria Chest Diseases Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5861-3454","authenticated-orcid":false,"given":"Grigorios","family":"Stratakos","sequence":"additional","affiliation":[{"name":"1st Respiratory Medicine Department of National and Kapodistrian University of Athens, Sotiria Chest Diseases Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9256-9656","authenticated-orcid":false,"given":"Petros","family":"Bakakos","sequence":"additional","affiliation":[{"name":"1st Respiratory Medicine Department of National and Kapodistrian University of Athens, Sotiria Chest Diseases Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0138-5582","authenticated-orcid":false,"given":"Nikoletta","family":"Rovina","sequence":"additional","affiliation":[{"name":"1st Respiratory Medicine Department of National and Kapodistrian University of Athens, Sotiria Chest Diseases Hospital, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Polverino, E., Goeminne, P.C., McDonnell, M.J., Aliberti, S., Marshall, S.E., Loebinger, M.R., Murris, M., Cant\u00f3n, R., Torres, A., and Dimakou, K. (2017). European Respiratory Society guidelines for the management of adult bronchiectasis. Eur. Respir. J., 50.","DOI":"10.1183\/13993003.00629-2017"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","article-title":"Advances in bronchiectasis: Endotyping, genetics, microbiome, and disease heterogeneity","volume":"392","author":"Flume","year":"2018","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Chalmers, J.D., Chang, A.B., Chotirmall, S.H., Dhar, R., and McShane, P.J. (2018). Bronchiectasis. Nat. Rev. Dis. Prim., 4.","DOI":"10.1038\/s41572-018-0042-3"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S2213-2600(23)00093-0","article-title":"Bronchiectasis in Europe: Data on disease characteristics from the European Bronchiectasis registry (EMBARC)","volume":"11","author":"Chalmers","year":"2023","journal-title":"Lancet Respir. Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Barbosa, M., and Chalmers, J.D. (2023). Bronchiectasis. Presse M\u00e9d., 52.","DOI":"10.1016\/j.lpm.2023.104174"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Mishra, M., Kumar, N., Jaiswal, A., Verma, A., and Kant, S. (2012). Kartagener\u2032s syndrome: A case series. Lung India, 29.","DOI":"10.4103\/0970-2113.102831"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Sch\u00e4fer, J., Griese, M., Chandrasekaran, R., Chotirmall, S.H., and Hartl, D. (2018). Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis. BMC Pulm. Med., 18.","DOI":"10.1186\/s12890-018-0630-8"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Zhou, W., Li, Y., Zheng, H., He, M., Zhang, M., Chen, Q., Situ, C., Wang, Y., Zhang, T., and Chen, K. (2025). Whole exome sequencing enhances diagnosis of hereditary bronchiectasis. Orphanet J. Rare Dis., 20.","DOI":"10.1186\/s13023-025-03661-z"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/resp.12832","article-title":"Aetiology of bronchiectasis in adults: A systematic literature review","volume":"21","author":"Gao","year":"2016","journal-title":"Respirology"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"G\u00f3mez-Olivas, J.D., Oscullo, G., and Mart\u00ednez-Garc\u00eda, M.\u00c1. (2023). Etiology of Bronchiectasis in the World: Data from the Published National and International Registries. J. Clin. Med., 12.","DOI":"10.3390\/jcm12185782"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1164\/rccm.201210-1937OC","article-title":"Lung Microbiota and Bacterial Abundance in Patients with Bronchiectasis when Clinically Stable and During Exacerbation","volume":"187","author":"Tunney","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1513\/AnnalsATS.201706-426OC","article-title":"The Prevalence and Significance of Staphylococcus aureus in Patients with Non\u2013Cystic Fibrosis Bronchiectasis","volume":"15","author":"Metersky","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_13","unstructured":"Sisodia, J., and Bajaj, T. (2025, July 06). Allergic Bronchopulmonary Aspergillosis, StatPearls [Internet], Available online: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK542329\/."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/CM9.0000000000002225","article-title":"Asthma, Bronchiectasis, and Chronic Obstructive Pulmonary disease: The Bermuda Triangle of the Airways","volume":"135","author":"Soriano","year":"2022","journal-title":"Chin. Med. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/COPD.S6133","article-title":"The pathophysiology of bronchiectasis","volume":"9","author":"King","year":"2009","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_16","first-page":"6","article-title":"Inflammation: A two-edged sword-the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"Eur. J. Respir. Dis. Suppl."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/s-0041-1730891","article-title":"Pathophysiology of Bronchiectasis","volume":"42","author":"Keir","year":"2021","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Raboso, B., Pou, C., Abril, R., Erro, M., S\u00e1nchez, C., Manzano, C., Zamarr\u00f3n, E., Suarez-Cuartin, G., and Gonz\u00e1lez, J. (2024). Bronchiectasis. Open Respir. Arch., 6.","DOI":"10.1016\/j.opresp.2024.100339"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/resp.13509","article-title":"Pathophysiology, causes and genetics of paediatric and adult bronchiectasis","volume":"24","author":"Bush","year":"2019","journal-title":"Respirology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.arbres.2022.09.004","article-title":"Pathophysiology of Chronic Bronchial Infection in Bronchiectasis","volume":"59","author":"Solarat","year":"2023","journal-title":"Arch. Bronconeumol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and Long-Term Antibiotic Treatment Reduces Airway and Systemic Inflammation in Non\u2013Cystic Fibrosis Bronchiectasis","volume":"186","author":"Chalmers","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Perea, L., Faner, R., Chalmers, J.D., and Sibila, O. (2024). Pathophysiology and genomics of bronchiectasis. Eur. Respir. Rev., 33.","DOI":"10.1183\/16000617.0055-2024"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","article-title":"Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: An international, observational, multicohort study","volume":"9","author":"Keir","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.164.9.2105083","article-title":"Bronchial Inflammation and Colonization in Patients with Clinically Stable Bronchiectasis","volume":"164","author":"Angrill","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1164\/rccm.201712-2423OC","article-title":"Blood Neutrophils Are Reprogrammed in Bronchiectasis","volume":"198","author":"Bedi","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1165\/rcmb.2018-0007OC","article-title":"Lung Defense Through IL-8 Carries a Cost of Chronic Lung Remodeling and Impaired Function","volume":"59","author":"Reynolds","year":"2018","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/thx.2003.008037","article-title":"Neutrophil apoptosis, proinflammatory mediators and cell counts in bronchiectasis","volume":"59","author":"Watt","year":"2004","journal-title":"Thorax"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.pulmoe.2023.03.004","article-title":"Endotypes in bronchiectasis: Moving towards precision medicine. A narrative review","volume":"29","author":"Martins","year":"2023","journal-title":"Pulmonology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1164\/rccm.200208-829OC","article-title":"Sputum Sol Neutrophil Elastase Activity in Bronchiectasis: Differential Modulation by Syndecan-1","volume":"168","author":"Chan","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"L835","DOI":"10.1152\/ajplung.1999.276.5.L835","article-title":"Neutrophil elastase increases MUC5AC mRNA and protein expression in respiratory epithelial cells","volume":"276","author":"Voynow","year":"1999","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Amati, F., Simonetta, E., Gramegna, A., Tarsia, P., Contarini, M., Blasi, F., and Aliberti, S. (2019). The biology of pulmonary exacerbations in bronchiectasis. Eur. Respir. Rev., 28.","DOI":"10.1183\/16000617.0055-2019"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil Elastase Activity Is Associated with Exacerbations and Lung Function Decline in Bronchiectasis","volume":"195","author":"Chalmers","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1165\/rcmb.2011-0380OC","article-title":"Influence of DNA on the Activities and Inhibition of Neutrophil Serine Proteases in Cystic Fibrosis Sputum","volume":"47","author":"Dubois","year":"2012","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Shoemark, A., Cant, E., Carreto, L., Smith, A., Oriano, M., Keir, H.R., Perea, L., Canto, E., Terranova, L., and Vidal, S. (2019). A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation. Eur. Respir. J., 53.","DOI":"10.1183\/13993003.00303-2019"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Dente, F.L., Bilotta, M., Bartoli, M.L., Bacci, E., Cianchetti, S., Latorre, M., Malagrin\u00f2, L., Nieri, D., Roggi, M.A., and Vagaggini, B. (2015). Neutrophilic Bronchial Inflammation Correlates with Clinical and Functional Findings in Patients with Noncystic Fibrosis Bronchiectasis. Mediat. Inflamm., 2015.","DOI":"10.1155\/2015\/642503"},{"key":"ref_36","first-page":"1602","article-title":"A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonisation on Prognosis in Adult Bronchiectasis","volume":"12","author":"Finch","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2147\/COPD.S121943","article-title":"Predicting high risk of exacerbations in bronchiectasis: The E-FACED score","volume":"12","author":"Athanazio","year":"2017","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/17476348.2021.1906225","article-title":"Pseudomonas aeruginosa in bronchiectasis: Infection, inflammation, and therapies","volume":"15","author":"Vidaillac","year":"2021","journal-title":"Expert Rev. Respir. Med."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ara\u00fajo, D., Shteinberg, M., Aliberti, S., Goeminne, P.C., Hill, A.T., Fardon, T.C., Obradovic, D., Stone, G., Trautmann, M., and Davis, A. (2018). The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis. Eur. Respir. J., 51.","DOI":"10.1183\/13993003.01953-2017"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s10096-019-03675-z","article-title":"Predicting factors for chronic colonization of Pseudomonas aeruginosa in bronchiectasis","volume":"38","author":"Pieters","year":"2019","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors Associated with Lung Function Decline in Adult Patients with Stable Non-Cystic Fibrosis Bronchiectasis","volume":"132","author":"Soriano","year":"2007","journal-title":"Chest"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Chalmers, J.D., Elborn, S., and Greene, C.M. (2023). Basic, translational and clinical aspects of bronchiectasis in adults. Eur. Respir. Rev., 32.","DOI":"10.1183\/16000617.0015-2023"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kavanaugh, J.S., Flack, C.E., Lister, J., Ricker, E.B., Ibberson, C.B., Jenul, C., Moormeier, D.E., Delmain, E.A., Bayles, K.W., and Horswill, A.R. (2019). Identification of Extracellular DNA-Binding Proteins in the Biofilm Matrix. mBio, 10.","DOI":"10.1128\/mBio.01137-19"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","article-title":"Characterization of the \u201cFrequent Exacerbator Phenotype\u201d in Bronchiectasis","volume":"197","author":"Chalmers","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_45","first-page":"809","article-title":"Bronchiectasis","volume":"108","author":"Rademacher","year":"2011","journal-title":"Dtsch. \u00c4rztebl. Int."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.202310-1729OC","article-title":"Endotypes of Exacerbation in Bronchiectasis: An Observational Cohort Study","volume":"210","author":"Gao","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"01131","DOI":"10.1183\/23120541.01131-2024","article-title":"Viruses in bronchiectasis","volume":"11","author":"Baker","year":"2025","journal-title":"ERJ Open Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/resp.14370","article-title":"Bronchiectasis: A pulmonary disease with systemic consequences","volume":"27","author":"Sibila","year":"2022","journal-title":"Respirology"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.rmed.2017.04.009","article-title":"The heterogeneity of systemic inflammation in bronchiectasis","volume":"127","author":"Saleh","year":"2017","journal-title":"Respir. Med."},{"key":"ref_50","first-page":"474","article-title":"Neutrophil-to-lymphocyte ratio, past, present and future perspectives","volume":"122","author":"Zahorec","year":"2021","journal-title":"Bratisl. Lek. Listy"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Georgakopoulou, V.E., Trakas, N., Damaskos, C., Garmpis, N., Karakou, E., Chatzikyriakou, R., Lambrou, P., and Tsiafaki, X. (2020). Neutrophils to Lymphocyte Ratio as a Biomarker in Bronchiectasis Exacerbation: A Retrospective Study. Cureus, 12.","DOI":"10.7759\/cureus.9728"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cyto.2017.08.005","article-title":"The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis","volume":"99","author":"Tsikrika","year":"2017","journal-title":"Cytokine"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.202108-1889OC","article-title":"Characterization of Eosinophilic Bronchiectasis: A European Multicohort Study","volume":"205","author":"Shoemark","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.chest.2023.04.029","article-title":"The U-Shaped Relationship Between Eosinophil Count and Bronchiectasis Severity","volume":"164","author":"Olveira","year":"2023","journal-title":"CHEST"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2021.02.016","article-title":"The basic immunology of asthma","volume":"184","author":"Hammad","year":"2021","journal-title":"Cell"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Brightling, C., and Greening, N. (2019). Airway inflammation in COPD: Progress to precision medicine. Eur. Respir. J., 54.","DOI":"10.1183\/13993003.00651-2019"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.mayocp.2021.04.025","article-title":"Eosinophils in Health and Disease: A State-of-the-Art Review","volume":"96","author":"Wechsler","year":"2021","journal-title":"Mayo Clin. Proc."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Pollock, J., Keir, H.R., Shoemark, A., Dicker, A.J., Giam, Y.H., Crichton, M.L., Cant, E., Huang, J.T.J., and Chalmers, J.D. (2022). Proteomic Markers of Eosinophilic Inflammation and Disease Severity in Bronchiectasis. Am. J. Respir. Crit. Care Med., 205.","DOI":"10.1164\/ajrccm-conference.2022.205.1_MeetingAbstracts.A2004"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1513\/AnnalsATS.201310-335OC","article-title":"A Novel Microbiota Stratification System Predicts Future Exacerbations in Bronchiectasis","volume":"11","author":"Rogers","year":"2014","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S2213-2600(20)30557-9","article-title":"The sputum microbiome and clinical outcomes in patients with bronchiectasis: A prospective observational study","volume":"9","author":"Dicker","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Wang, X., Villa, C., Dobarganes, Y., Olveira, C., Gir\u00f3n, R., Garc\u00eda-Clemente, M., M\u00e1iz, L., Sibila, O., Golpe, R., and Men\u00e9ndez, R. (2021). Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18168431"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Dai, Z., Zhong, Y., Cui, Y., Ma, Y., Zeng, H., and Chen, Y. (2024). Analysis of clinical characteristics, prognosis and influencing factors in patients with bronchiectasis-chronic obstructive pulmonary disease overlap syndrome: A prospective study for more than five years. J. Glob. Health, 14.","DOI":"10.7189\/jogh.14.04129"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1164\/rccm.202108-1943OC","article-title":"Endotyping Chronic Obstructive Pulmonary Disease, Bronchiectasis, and the \u201cChronic Obstructive Pulmonary Disease-Bronchiectasis Association\u201d","volume":"206","author":"Huang","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Oscullo, G., G\u00f3mez-Olivas, J.D., Ingles, M., Mompean, S., Martinez-Perez, R., Suarez-Cuartin, G., la Rosa-Carrillo, D., and Martinez-Garcia, M.A. (2023). Bronchiectasis-COPD Overlap Syndrome: Role of Peripheral Eosinophil Count and Inhaled Corticosteroid Treatment. J. Clin. Med., 12.","DOI":"10.3390\/jcm12196417"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1159\/000507228","article-title":"The Link between Asthma and Bronchiectasis: State of the Art","volume":"99","author":"Crimi","year":"2020","journal-title":"Respiration"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jaci.2024.01.027","article-title":"Bronchiectasis and asthma: Data from the European Bronchiectasis Registry (EMBARC)","volume":"153","author":"Polverino","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/02770903.2020.1857395","article-title":"Impact of asthma on bronchiectasis severity and risk of exacerbations","volume":"59","author":"Ferri","year":"2022","journal-title":"J. Asthma"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Zhang, P.-A., Wang, J.-L., Fu, S.-Y., Luo, H.-L., Qin, R.-D., and Li, J. (2025). Mediators of the association between allergic diseases and bronchiectasis: A bi-directional univariable and multivariable Mendelian randomization study and mediation analysis. World Allergy Organ. J., 18.","DOI":"10.1016\/j.waojou.2025.101038"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.chest.2024.06.3843","article-title":"Aspergillus Serologic Findings and Clinical Outcomes in Patients with Bronchiectasis","volume":"167","author":"Pollock","year":"2025","journal-title":"Chest"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaip.2025.03.005","article-title":"Impact of Bronchiectasis Severity on Clinical Outcomes in Patients with Allergic Bronchopulmonary Aspergillosis: A Retrospective Cohort Study","volume":"13","author":"Sehgal","year":"2025","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1164\/rccm.202303-0499OC","article-title":"Inflammatory Molecular Endotypes in Bronchiectasis: A European Multicenter Cohort Study","volume":"208","author":"Choi","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/all.13184","article-title":"Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: Comparison with different sputum phenotypes","volume":"72","author":"Ntontsi","year":"2017","journal-title":"Allergy"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Papaioannou, A.I., Fouka, E., Ntontsi, P., Stratakos, G., and Papiris, S. (2022). Paucigranulocytic Asthma: Potential Pathogenetic Mechanisms, Clinical Features and Therapeutic Management. J. Pers. Med., 12.","DOI":"10.3390\/jpm12050850"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.rmed.2011.01.015","article-title":"Elevated peripheral airway nitric oxide in bronchiectasis reflects disease severity","volume":"105","author":"Shoemark","year":"2011","journal-title":"Respir. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1183\/09031936.00069007","article-title":"Mucosal inflammation in idiopathic bronchiectasis: Cellular and molecular mechanisms","volume":"31","author":"Fuschillo","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/rmed.2001.1155","article-title":"Macrophages, neutrophils and tumour necrosis factor-\u03b1 expression in bronchiectatic airways in vivo","volume":"95","author":"Zheng","year":"2001","journal-title":"Respir. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00408-014-9619-0","article-title":"Low-dose clarithromycin therapy modulates Th17 response in non-cystic fibrosis bronchiectasis patients","volume":"192","author":"Fouka","year":"2014","journal-title":"Lung"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Frija-Masson, J., Martin, C., Regard, L., Lothe, M.-N., Touqui, L., Durand, A., Lucas, B., Damotte, D., Alifano, M., and Fajac, I. (2017). Bacteria-driven peribronchial lymphoid neogenesis in bronchiectasis and cystic fibrosis. Eur. Respir. J., 49.","DOI":"10.1183\/13993003.01873-2016"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/thx.53.8.685","article-title":"Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis","volume":"53","author":"Gaga","year":"1998","journal-title":"Thorax"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Okabayashi, H., Baba, T., Ootoshi, R., Shintani, R., Tabata, E., Ikeda, S., Niwa, T., Oda, T., Okuda, R., and Sekine, A. (2020). Evaluation of lymphocytic infiltration in the bronchial glands of Sj\u00f6gren\u2019s syndrome in transbronchial lung cryobiopsy. BMC Pulm. Med., 20.","DOI":"10.1186\/s12890-020-01318-0"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/thx.44.8.668","article-title":"The immunological component of the cellular inflammatory infiltrate in bronchiectasis","volume":"44","author":"Silva","year":"1989","journal-title":"Thorax"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"82. Eller, J., Silva, J.R.L.E., Poulter, L.W., Lode, H., and Cole, P.J. (1994). Cells and Cytokines in Chronic Bronchial Infection: CELLS & CYTOKINES. Ann. N. Y. Acad. Sci., 725, 331\u2013345.","DOI":"10.1111\/j.1749-6632.1994.tb39816.x"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Fouka, E., Lind\u00e9n, A., and Bossios, A. (2025). The role of T-helper and T regulatory cells in driving neutrophilic and eosinophilic inflammation in bronchiectasis. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1598257"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: The BAT randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): A randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1183\/09031936.00119114","article-title":"Management of bronchiectasis in adults","volume":"45","author":"Chalmers","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.chest.2024.01.045","article-title":"The Efficacy and Safety of Inhaled Antibiotics for the Treatment of Bronchiectasis in Adults: Updated Systematic Review and Meta-Analysis","volume":"166","author":"Cordeiro","year":"2024","journal-title":"Chest"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-2600(18)30427-2","article-title":"Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): Two phase 3, randomised controlled trials","volume":"7","author":"Haworth","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"De Soyza, A., Aksamit, T., Bandel, T.-J., Criollo, M., Elborn, J.S., Operschall, E., Polverino, E., Roth, K., Winthrop, K.L., and Wilson, R. (2018). RESPIRE 1: A phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis. Eur. Respir. J., 51.","DOI":"10.1183\/13993003.02053-2017"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/thorax-2024-221825","article-title":"Use of inhaled corticosteroids in bronchiectasis: Data from the European Bronchiectasis Registry (EMBARC)","volume":"80","author":"Pollock","year":"2025","journal-title":"Thorax"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s40265-022-01785-1","article-title":"Inhaled Corticosteroids in Adults with Non-cystic Fibrosis Bronchiectasis: From Bench to Bedside. A Narrative Review","volume":"82","author":"Oscullo","year":"2022","journal-title":"Drugs"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.2147\/COPD.S311236","article-title":"Inhaled Corticosteroid Therapy in Bronchiectasis is Associated with All-Cause Mortality: A Prospective Cohort Study","volume":"16","author":"Fjaellegaard","year":"2021","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Rademacher, J., Konwert, S., Fuge, J., Dettmer, S., Welte, T., and Ringshausen, F.C. (2020). Anti-IL5 and anti-IL5R\u03b1 therapy for clinically significant bronchiectasis with eosinophilic endotype: A case series. Eur. Respir. J., 55.","DOI":"10.1183\/13993003.01333-2019"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJMoa2411664","article-title":"Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis","volume":"392","author":"Chalmers","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMe2502618","article-title":"Brensocatib in Bronchiectasis\u2014A New Sheriff in Town?","volume":"392","author":"Bell","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Cipolla, D., Zhang, J., Korkmaz, B., Chalmers, J.D., Basso, J., Lasala, D., Fernandez, C., Teper, A., Mange, K.C., and Perkins, W.R. (2023). Dipeptidyl peptidase-1 inhibition with brensocatib reduces the activity of all major neutrophil serine proteases in patients with bronchiectasis: Results from the WILLOW trial. Respir. Res., 24.","DOI":"10.1186\/s12931-023-02444-z"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"00505-2024","DOI":"10.1183\/23120541.00505-2024","article-title":"Brensocatib in patients with bronchiectasis: Subgroup analyses from the WILLOW trial","volume":"11","author":"Chalmers","year":"2025","journal-title":"ERJ Open Res."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"00695","DOI":"10.1183\/23120541.00695-2022","article-title":"Benefit\u2212risk assessment of brensocatib for treatment of non-cystic fibrosis bronchiectasis","volume":"9","author":"Chalmers","year":"2023","journal-title":"ERJ Open Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/rccm.201906-1219OC","article-title":"Airway Mucus Hyperconcentration in Non\u2013Cystic Fibrosis Bronchiectasis","volume":"201","author":"Ramsey","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/15\/10\/499\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T07:55:27Z","timestamp":1760687727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/15\/10\/499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":100,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["jpm15100499"],"URL":"https:\/\/doi.org\/10.3390\/jpm15100499","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]}}}